ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Kimera® Labs Files First FDA Investigational New Drug (IND) Application Using XoGlo® for Treatment of ARDS Secondary to COVID-19
August 19, 2020Kimera® Labs Inc, a privately held clinical stage biotechnology company, announces the filing of an extended FDA Investigational New Drug (IND) application to study the treatment of COVID-19 related inflammatory disease using Kimera's first-in-class ...
Pharma Sources Insight January 2025
